Fujifilm Diosynth Biotechnologies - pAVEway™: A Novel Platform for the Advanced Production of Protein Therapeutics

Fujifilm Diosynth Biotechnologies has over 180 process development scientists who have experience with over 140 proteins.

• 
  The pAVEway™ platform developed by Fujifilm Diosynth Biotechnologies is...
• 
  Fujifilm Diosynth Biotechnologies has over 180 process development scientists...
• 
  A pre-cGMP pilot-scale fermenter ensures that processes can be rapidly...
• 
  A full range of manufacturing support services is offered, including...
• 
  On-site cGMP cell banking facilities for the production of master and working...

Back to Company Details